Features of PRCA:

1. Anemia: The hallmark symptom of PRCA is anemia, which can cause fatigue, weakness, pallor, and shortness of breath.
2. Patients are usually treated with blood transfusion multiple times before being referred for further evaluation by a hematologist.

Etiology:

The causes of PRCA can be classified into two main categories:

• Primary (idiopathic): The cause is unknown, and this form is sometimes seen in association with autoimmune diseases.
• Secondary: This can occur due to infections (such as parvovirus B19), drugs (such as certain chemotherapy agents), malignancies (e.g., thymoma), or other conditions like lupus or rheumatoid arthritis. Bone marrow is essential to differentiate among primary and secondary causes of PRCA.

Causes of Secondary PRCA:

• Parvovirus B19: This virus can infect the bone marrow and specifically target erythroid precursors, causing PRCA. It is commonly seen in children but can affect adults as well.
• Thymoma: A tumor of the thymus gland can sometimes be associated with PRCA, though this is relatively rare.
• Autoimmune Disorders: Conditions like systemic lupus erythematosus (SLE) and rheumatoid arthritis may be associated with PRCA as a result of immune system dysfunction.
• Medications and Chemicals: Some medications, such as certain chemotherapy drugs and immunosuppressants, can lead to PRCA as a side effect.
• Malignancies( cancers) : Certain cancers like hematological malignancies (chronic lymphocytic leukemia) can leads to PRCA which usually responds to treatment.

Diagnosis:

The diagnosis of PRCA typically involves:

• Blood Tests: A complete blood count (CBC) showing anemia, with a reduced reticulocyte count (which reflects red blood cell production).
• Bone Marrow Aspiration and biopsy: This is crucial to confirm the diagnosis. The bone marrow aspirate typically shows an absence or severe reduction in red blood cell precursors, while the production of white blood cells and platelets remains intact. It also rules out other pathologies which may be responsible for PRCA.
• Other Tests: To identify potential secondary causes, such as viral infections (e.g., Parvovirus B19), autoimmune testing, and imaging to detect any underlying malignancy like thymoma.

Treatment:

The treatment of PRCA depends on its underlying cause:

• Immunosuppressive Therapy: In cases where an autoimmune cause is suspected (such as in idiopathic PRCA), corticosteroids or other immunosuppressive drugs may be used.
• Blood Transfusions: These can help manage symptoms of anemia, especially in severe cases, but they are not a long-term solution. They are also associated with risk of blood transmitted infections, so they should be used selectively on case by case basis.
• Management of Underlying Causes: For secondary PRCA, treating the underlying condition (e.g., antivirals for Parvovirus B19, removal of thymoma, or stopping offending medications) is essential.
• Erythropoiesis-stimulating agents (ESA): These drugs can sometimes help stimulate the production of red blood cells in PRCA patients, particularly in cases where the bone marrow is capable of responding.

The prognosis for individuals with PRCA can vary widely, depending on whether the cause is primary or secondary, and how effectively the underlying condition is managed.

Patient needs to be on medications for prolonged period before they are discontinued.